The global poultry drugs market valued at USD 5100 Mn by 2021 and expected to reach USD 9323 Mn by 2028 growing at a CAGR of 9% during the forecast period 2022 to 2028. Global Poultry Drugs Market is the chemical substances used to diagnose, treat, prevent, or cure the various diseases. Global Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others. The worldwide poultry medicines market is likely to be hampered by low product exclusivity, generic competition, and tight regulations. In the animal health care market, product exclusivity lasts only three to five years. Increased competition from generics and over-the-counter (OTC) products occurs from a shorter exclusivity period. Furthermore, the market’s expansion is hampered by strict product approval rules and limited vaccine production. In addition, rising worries about the use of antibiotics and growth boosters in chicken are projected to stifle market expansion. Hormonal components and antibiotics are examples of growth boosters that are commonly employed in food or meat-producing animals, such as chicken. There is significant evidence that poultry antibiotics have a harmful influence on people, including the development of antimicrobial-resistant bacteria and disruption of normal human intestinal flora. Domesticated birds such as ducks, chickens, turkeys, geese, quails, and other birds kept by humans are known as poultry animals. The poultry sector is one of the most rapidly expanding segments of the livestock industry. The report’s scope stresses the importance of poultry animal care, for which the veterinarian is a critical link for companies seeking to improve the health and wellbeing of poultry animals.